• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Mounjaro

anonymous

Guest
When do you expect to get the indication to treat obesity? I can’t get Wegovy, it’s been 3 months and I can’t start therapy! Mounjaro apoears to have better weight loss anyway. Does Lilly expect to have shortages as well?
 

<



When do you expect to get the indication to treat obesity? I can’t get Wegovy, it’s been 3 months and I can’t start therapy! Mounjaro apoears to have better weight loss anyway. Does Lilly expect to have shortages as well?
What is "better"? Has there been any H2H Phase 3 trials?

Remember, that Actos lowered A1C by 2.6 and Avandia by only 1.9 or something. Different patient populations, and you can't compare across studies. However, you can "buy" the Endocrinologists in your district to parrot the BS out of the marketing team in Indy.

What a garbage industry.
 




Similar threads

Replies
5
Views
1K
Replies
21
Views
6K
Replies
3
Views
2K
Replies
17
Views
8K